Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 23163616)

1.

Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.

Kelly CP, Green PH, Murray JA, Dimarino A, Colatrella A, Leffler DA, Alexander T, Arsenescu R, Leon F, Jiang JG, Arterburn LA, Paterson BM, Fedorak RN; Larazotide Acetate Celiac Disease Study Group.

Aliment Pharmacol Ther. 2013 Jan;37(2):252-62. doi: 10.1111/apt.12147. Epub 2012 Nov 19.

PMID:
23163616
2.

A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.

Leffler DA, Kelly CP, Abdallah HZ, Colatrella AM, Harris LA, Leon F, Arterburn LA, Paterson BM, Lan ZH, Murray JA.

Am J Gastroenterol. 2012 Oct;107(10):1554-62. doi: 10.1038/ajg.2012.211. Epub 2012 Jul 24.

3.

Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.

Leffler D, Schuppan D, Pallav K, Najarian R, Goldsmith JD, Hansen J, Kabbani T, Dennis M, Kelly CP.

Gut. 2013 Jul;62(7):996-1004. doi: 10.1136/gutjnl-2012-302196. Epub 2012 May 22.

4.

Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.

Leffler DA, Kelly CP, Green PH, Fedorak RN, DiMarino A, Perrow W, Rasmussen H, Wang C, Bercik P, Bachir NM, Murray JA.

Gastroenterology. 2015 Jun;148(7):1311-1319.e6. doi: 10.1053/j.gastro.2015.02.008. Epub 2015 Feb 13.

PMID:
25683116
5.

Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.

Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M.

Gastroenterology. 2014 Jun;146(7):1649-58. doi: 10.1053/j.gastro.2014.02.031. Epub 2014 Feb 25.

PMID:
24583059
6.

Exploratory, randomized, double-blind, placebo-controlled study on the effects of Bifidobacterium infantis natren life start strain super strain in active celiac disease.

Smecuol E, Hwang HJ, Sugai E, Corso L, Cherñavsky AC, Bellavite FP, González A, Vodánovich F, Moreno ML, Vázquez H, Lozano G, Niveloni S, Mazure R, Meddings J, Mauriño E, Bai JC.

J Clin Gastroenterol. 2013 Feb;47(2):139-47. doi: 10.1097/MCG.0b013e31827759ac.

PMID:
23314670
7.

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study.

Paterson BM, Lammers KM, Arrieta MC, Fasano A, Meddings JB.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):757-66.

8.

Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.

Tack GJ, van de Water JM, Bruins MJ, Kooy-Winkelaar EM, van Bergen J, Bonnet P, Vreugdenhil AC, Korponay-Szabo I, Edens L, von Blomberg BM, Schreurs MW, Mulder CJ, Koning F.

World J Gastroenterol. 2013 Sep 21;19(35):5837-47. doi: 10.3748/wjg.v19.i35.5837.

9.

Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.

Kaukinen K, Peräaho M, Collin P, Partanen J, Woolley N, Kaartinen T, Nuutinen T, Halttunen T, Mäki M, Korponay-Szabo I.

Scand J Gastroenterol. 2005 May;40(5):564-72.

PMID:
16036509
10.

Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.

Koskinen O, Collin P, Korponay-Szabo I, Salmi T, Iltanen S, Haimila K, Partanen J, Mäki M, Kaukinen K.

J Pediatr Gastroenterol Nutr. 2008 Oct;47(4):436-42. doi: 10.1097/MPG.0b013e31817b6dec.

PMID:
18852635
11.

Randomised clinical trial: gluten may cause depression in subjects with non-coeliac gluten sensitivity - an exploratory clinical study.

Peters SL, Biesiekierski JR, Yelland GW, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2014 May;39(10):1104-12. doi: 10.1111/apt.12730. Epub 2014 Apr 1.

PMID:
24689456
12.

Double-blind randomized controlled trial of rifaximin for persistent symptoms in patients with celiac disease.

Chang MS, Minaya MT, Cheng J, Connor BA, Lewis SK, Green PH.

Dig Dis Sci. 2011 Oct;56(10):2939-46. doi: 10.1007/s10620-011-1719-6. Epub 2011 Jun 7.

PMID:
21647654
13.

IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease.

Kaukinen K, Sulkanen S, Mäki M, Collin P.

Eur J Gastroenterol Hepatol. 2002 Mar;14(3):311-5.

PMID:
11953698
14.

Reintroduction of gluten following flour transamidation in adult celiac patients: a randomized, controlled clinical study.

Mazzarella G, Salvati VM, Iaquinto G, Stefanile R, Capobianco F, Luongo D, Bergamo P, Maurano F, Giardullo N, Malamisura B, Rossi M.

Clin Dev Immunol. 2012;2012:329150. doi: 10.1155/2012/329150. Epub 2012 Jul 31.

15.

Larazotide acetate regulates epithelial tight junctions in vitro and in vivo.

Gopalakrishnan S, Durai M, Kitchens K, Tamiz AP, Somerville R, Ginski M, Paterson BM, Murray JA, Verdu EF, Alkan SS, Pandey NB.

Peptides. 2012 May;35(1):86-94. doi: 10.1016/j.peptides.2012.02.015. Epub 2012 Feb 27.

PMID:
22401908
16.

Enzyme therapy for management of coeliac disease.

Cornell HJ, Macrae FA, Melny J, Pizzey CJ, Cook F, Mason S, Bhathal PS, Stelmasiak T.

Scand J Gastroenterol. 2005 Nov;40(11):1304-12.

PMID:
16243716
17.

Low-dose gluten challenge in celiac sprue: malabsorptive and antibody responses.

Pyle GG, Paaso B, Anderson BE, Allen D, Marti T, Khosla C, Gray GM.

Clin Gastroenterol Hepatol. 2005 Jul;3(7):679-86.

PMID:
16206501
18.

Two-year follow-up of anti-transglutaminase autoantibodies among celiac children on gluten-free diet: comparison of IgG and IgA.

Martín-Pagola A, Ortiz-Paranza L, Bilbao JR, de Nanclares GP, Estevez EP, Castaño L, Vitoria JC.

Autoimmunity. 2007 Mar;40(2):117-21.

PMID:
17364503
19.

Antibodies to recombinant human tissue-transglutaminase in coeliac disease: diagnostic effectiveness and decline pattern after gluten-free diet.

Bazzigaluppi E, Roggero P, Parma B, Brambillasca MF, Meroni F, Mora S, Bosi E, Barera G.

Dig Liver Dis. 2006 Feb;38(2):98-102. Epub 2005 Dec 28.

PMID:
16386476
20.

A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.

Catassi C, Fabiani E, Iacono G, D'Agate C, Francavilla R, Biagi F, Volta U, Accomando S, Picarelli A, De Vitis I, Pianelli G, Gesuita R, Carle F, Mandolesi A, Bearzi I, Fasano A.

Am J Clin Nutr. 2007 Jan;85(1):160-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk